ORIC Pharmaceuticals advances rinzimetostat into the global Phase 3 Himalayas-1 trial for mCRPC, with full global rights.

Helus Pharma said it completed enrollment ahead of schedule in the Phase 3 study evaluating HLP003 as an adjunctive treatment ...

Feedback from the U.S. Food and Drug Administration (FDA) supports acceleration of OMT-28’s development path directly into a pivotal Phase 3 studyWith the vast majority of PMD patients having no ...

Armata Pharmaceuticals is a Hold until Phase 3 AP-SA02 data, given a funding-dependent profile and limited margin for error.

HLP003 previously granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration ("FDA”) HLP003 Phase 2 data demonstrated durable efficacy, with a mean ~23-po ...

Key Points Interested in Agenus Inc.? Here are five stocks we like better. Agenus is prioritizing its Phase 3 ROBBIN trial of ...

First patient dosed in Phase 3 LUTEON[1] trial evaluating TLX250-Tx in relapsed or recurrent clear cell renal cell carcinoma (ccRCC).

SLB OneSubsea will supply subsea production systems for 13 wells.

Score another one for amyloid immunotherapy. The anti-pyroglutamated amyloid antibody donanemab has posted positive top-line results in the Phase 3 Trailblazer-Alz2 study, according to an Eli Lilly ...